These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2492235)

  • 1. Studies on folliculogenesis and in vitro fertilization outcome after the administration of follicle-stimulating hormone at different times during the menstrual cycle.
    Sharma V; Riddle A; Mason B; Whitehead M; Collins W
    Fertil Steril; 1989 Feb; 51(2):298-303. PubMed ID: 2492235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients.
    Karande VC; Jones GS; Veeck LL; Muasher SJ
    Fertil Steril; 1990 Mar; 53(3):486-9. PubMed ID: 2106455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific effects of FSH and LH on follicular development and oocyte retrieval as determined by a program for in vitro fertilization.
    Seegar Jones GE; Acosta AA; Garcia JE; Rosenwaks Z
    Ann N Y Acad Sci; 1985; 442():119-22. PubMed ID: 3925831
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization.
    MacLachlan V; Besanko M; O'Shea F; Wade H; Wood C; Trounson A; Healy DL
    N Engl J Med; 1989 May; 320(19):1233-7. PubMed ID: 2496310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso T; Lobo R; Paulson RJ
    Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration.
    Lejeune B; Degueldre M; Camus M; Vekemans M; Opsomer L; Leroy F
    Fertil Steril; 1986 Mar; 45(3):377-83. PubMed ID: 3949037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
    de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
    Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation.
    Kolibianakis E; Zikopoulos K; Camus M; Tournaye H; Van Steirteghem A; Devroey P
    Hum Reprod; 2004 Nov; 19(11):2545-9. PubMed ID: 15471941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up.
    Kolibianakis E; Bourgain C; Albano C; Osmanagaoglu K; Smitz J; Van Steirteghem A; Devroey P
    Fertil Steril; 2002 Nov; 78(5):1025-9. PubMed ID: 12413988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An artificially induced follicle stimulating hormone surge at the time of human chorionic gonadotrophin administration in controlled ovarian stimulation cycles has no effect on cumulus expansion, fertilization rate, embryo quality and implantation rate.
    Vermeiden JP; Roseboom TJ; Goverde AJ; Suchartwatnachai C; Schoute E; Braat DD; Schats R
    Hum Reprod; 1997 Jul; 12(7):1399-402. PubMed ID: 9262265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis.
    Filicori M; Cognigni GE; Taraborrelli S; Parmegiani L; Bernardi S; Ciampaglia W
    Fertil Steril; 2002 Aug; 78(2):414-6. PubMed ID: 12137883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso TM; Lobo RA; Paulson RJ
    J Assist Reprod Genet; 1996 Jan; 13(1):49-52. PubMed ID: 8825167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administering human chorionic gonadotropin injections for triggering follicle maturation could impact fertility during the subsequent menstrual cycle.
    Fukuda J; Abe T; Okuno T; Kobayashi T; Kato K
    Int J Gynaecol Obstet; 2016 Mar; 132(3):309-13. PubMed ID: 26643301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
    Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z
    Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.